Average Co-Inventor Count = 5.69
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cylene Pharmaceuticals, Inc. (8 from 21 patents)
2. Vertex Pharmaceuticals, Inc. (7 from 1,151 patents)
3. Senhwa Biosciences, Inc. (4 from 11 patents)
4. Novartis Ag (1 from 3,923 patents)
20 patents:
1. 12319693 - Crystalline forms of CFTR modulators
2. 12122788 - Process of making CFTR modulators
3. 11873300 - Crystalline forms of CFTR modulators
4. 11866450 - Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
5. 11591350 - Modulators of cystic fibrosis transmembrane conductance regulator
6. 11584761 - Process of making CFTR modulators
7. 11066417 - Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
8. 9303033 - Pyrazolopyrimidines and related heterocycles as CK2 inhibitors
9. 9062043 - Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators
10. 8853234 - Quinolone analogs and methods related thereto
11. 8575177 - Pyrazolopyrimidines and related heterocycles as CK2 inhibitors
12. 8168651 - Protein kinase modulators
13. 7928100 - Quinolone analogs and methods related thereto
14. 7910600 - Therapeutic kinase modulators
15. 7834180 - Methods of preparing quinolone analogs